Sort by:




AgEcon Search 25 records found 1 - 10nextlast  jump to record: Search took 0.03 seconds. 
EU lawmakers have been successfully struggling for a quarter of a century to refuse the cultivation of “Genetically Modified Organisms” on the Old Continent. A clear [...]
17 June 2016 | Conference Paper/ Presentation |
Several characteristics of biotech industry structure follow cyclical patterns. Mergers and acquisitions activity shows cyclical behavior, with peaks from 1988-92 and 199 [...]
1999 | Working or Discussion Paper |
Over the past fifteen years, the agricultural biotechnology industry has exhibited cyclical behavior in concentration and consolidation. This paper provides a theoretica [...]
1999 | Working or Discussion Paper |
Production and processing of genetically modified organisms (GMO) in line with the European food safety and labelling regulations lead to an elevated risk of unintentiona [...]
2009 | Conference Paper/ Presentation |
The mycotoxin fumonisin is associated with oesophageal cancer and birth defects. The Eastern Cape province of South Africa has high levels of fumonisin in maize and oesop [...]
2009 | Conference Paper/ Presentation |
The emergence of agricultural biotechnology and policy responses to is altering global agricultural trade patterns. This paper models the effects of restrictive policies [...]
1999 | Working or Discussion Paper |
The paper analyzes the welfare effects of the introduction of GMO technology into a market in which a fraction of consumers refuses to buy GMOs. Our theoretical model r [...]
2003 | Conference Paper/ Presentation |
The question in the title is divided into: (1) Can we trade the current generation of products from biotech or the technology itself? and (2) Can we trade the future gene [...]
2001 | Journal Article |
A survey of 600 consumers was conducted in Nairobi to determine attitudes and willingness to pay (WTP) for GM maize meal. WTP was estimated using the double-bounded logit [...]
2005 | Conference Paper/ Presentation |
This paper proposes an analytical framework to examine the market and welfare impacts of GMOs, when some consumers refuse genetically modified organisms (GMOs) and when t [...]
2002 | Conference Paper/ Presentation |